{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:58:09Z","timestamp":1792119489981,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41397-026-00403-7","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:01:03Z","timestamp":1773331263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumour immune cell infiltration and response to FOLFOX or FOLFIRI chemotherapy in colorectal cancer"],"prefix":"10.1038","volume":"26","author":[{"given":"Jia","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3435-7289","authenticated-orcid":false,"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"403_CR1","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ebiom.2019.09.050","volume":"48","author":"A Montalban-Arques","year":"2019","unstructured":"Montalban-Arques A, Scharl M. Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy. EBioMedicine. 2019;48:648\u201355.","journal-title":"EBioMedicine"},{"key":"403_CR2","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"403_CR3","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.2147\/OTT.S163891","volume":"11","author":"XG Zhou","year":"2018","unstructured":"Zhou XG, Huang XL, Liang SY, Tang SM, Wu SK, Huang TT, et al. Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis. Onco Targets Ther. 2018;11:2815\u201330.","journal-title":"Onco Targets Ther"},{"key":"403_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: A review. JAMA. 2021;325:669\u201385.","journal-title":"JAMA"},{"key":"403_CR5","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1200\/JCO.22.02774","volume":"41","author":"C Tournigand","year":"2023","unstructured":"Tournigand C, Andr\u00e9 T, Achille E, Lledo G, Flesh M, Mery-Mignard D, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR Study. J Clin Oncol. 2023;41:3469\u201377.","journal-title":"J Clin Oncol"},{"key":"403_CR6","first-page":"373","volume":"356","author":"M Buyse","year":"2000","unstructured":"Buyse M, Thirion P, Carlson RW, Burzykowski T, Molenberghs G, Piedbois P. Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer. Lancet. 2000;356:373\u20138.","journal-title":"Meta-Analysis Group in Cancer. Lancet"},{"key":"403_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1019-x","volume":"18","author":"JL Hu","year":"2019","unstructured":"Hu JL, Wang W, Lan XL, Zeng ZC, Liang YS, Yan YR, et al. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Mol Cancer. 2019;18:91.","journal-title":"Mol Cancer"},{"key":"403_CR8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/ijms22020753","volume":"22","author":"S Ghatak","year":"2021","unstructured":"Ghatak S, Hascall VC, Markwald RR, Misra S. FOLFOX therapy induces feedback upregulation of CD44v6 through YB-1 to maintain stemness in colon initiating cells. Int J Mol Sci. 2021;22:753.","journal-title":"Int J Mol Sci"},{"key":"403_CR9","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/JTO.0b013e3182037b76","volume":"6","author":"RM Bremnes","year":"2011","unstructured":"Bremnes RM, Al-Shibli K, Donnem T, Sirera R, Al-Saad S, Andersen S, et al. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J Thorac Oncol. 2011;6:824\u201333.","journal-title":"J Thorac Oncol"},{"key":"403_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8:761\u201373.","journal-title":"J Cancer"},{"key":"403_CR11","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pag\u00e8s","year":"2018","unstructured":"Pag\u00e8s F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391:2128\u201339.","journal-title":"Lancet"},{"key":"403_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/cancers15020418","volume":"15","author":"B Mlecnik","year":"2023","unstructured":"Mlecnik B, Lugli A, Bindea G, Marliot F, Bifulco C, Lee JJ, et al. Multicenter international study of the consensus immunoscore for the prediction of relapse and survival in early-stage colon cancer. Cancers (Basel). 2023;15:418.","journal-title":"Cancers (Basel)"},{"key":"403_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon J, Bruni D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat Rev Drug Discov. 2019;18:197\u2013218.","journal-title":"Nat Rev Drug Discov"},{"key":"403_CR14","doi-asserted-by":"publisher","first-page":"801484","DOI":"10.3389\/fgene.2022.801484","volume":"13","author":"L Cao","year":"2022","unstructured":"Cao L, Li T, Ba Y, Chen E, Yang J, Zhang H. Exploring immune-related prognostic signatures in the tumor microenvironment of colon cancer. Front Genet. 2022;13:801484.","journal-title":"Front Genet"},{"key":"403_CR15","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960\u20134.","journal-title":"Science"},{"key":"403_CR16","doi-asserted-by":"publisher","first-page":"e001813","DOI":"10.1136\/jitc-2020-001813","volume":"9","author":"M Kie\u00dfler","year":"2021","unstructured":"Kie\u00dfler M, Plesca I, Sommer U, Wehner R, Wilczkowski F, M\u00fcller L, et al. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer. J Immunother Cancer. 2021;9:e001813.","journal-title":"J Immunother Cancer"},{"key":"403_CR17","doi-asserted-by":"publisher","first-page":"113787","DOI":"10.1016\/j.biopha.2022.113787","volume":"155","author":"WQ Wang","year":"2022","unstructured":"Wang WQ, Zhang L, Yang F, Zhou HH, Zhang W, Zou Y, et al. Patterns of immune infiltration and survival in endocrine therapy-treated ER-positive breast cancer: A computational study of 1900 patients. Biomed Pharmacother. 2022;155:113787.","journal-title":"Biomed Pharmacother"},{"key":"403_CR18","doi-asserted-by":"publisher","first-page":"102602","DOI":"10.1016\/j.ebiom.2019.102602","volume":"51","author":"R Liu","year":"2020","unstructured":"Liu R, Hu R, Zeng Y, Zhang W, Zhou HH. Tumour immune cell infiltration and survival after platinum-based chemotherapy in high-grade serous ovarian cancer subtypes: A gene expression-based computational study. EBioMedicine. 2020;51:102602.","journal-title":"EBioMedicine"},{"key":"403_CR19","doi-asserted-by":"publisher","first-page":"685370","DOI":"10.3389\/fimmu.2021.685370","volume":"12","author":"R Liu","year":"2021","unstructured":"Liu R, Yang F, Yin JY, Liu YZ, Zhang W, Zhou HH. Influence of tumor immune infiltration on immune checkpoint inhibitor therapeutic efficacy: a computational retrospective study. Front Immunol. 2021;12:685370.","journal-title":"Front Immunol"},{"key":"403_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382.","journal-title":"Nat Biotechnol"},{"key":"403_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/bjc.2011.505","volume":"106","author":"S Tsuji","year":"2012","unstructured":"Tsuji S, Midorikawa Y, Takahashi T, Yagi K, Takayama T, Yoshida K, et al. Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis. Br J Cancer. 2012;106:126\u201332.","journal-title":"Br J Cancer"},{"key":"403_CR22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2006.07.4187","volume":"25","author":"M Del Rio","year":"2007","unstructured":"Del Rio M, Molina F, Bascoul-Mollevi C, Copois V, Bibeau F, Chalbos P, et al. Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan. J Clin Oncol. 2007;25:773\u201380.","journal-title":"J Clin Oncol"},{"key":"403_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejca.2017.02.003","volume":"76","author":"M Del Rio","year":"2017","unstructured":"Del Rio M, Mollevi C, Bibeau F, Vie N, Selves J, Emile JF, et al. Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies. Eur J Cancer. 2017;76:68\u201375.","journal-title":"Eur J Cancer"},{"key":"403_CR24","doi-asserted-by":"publisher","first-page":"953321","DOI":"10.3389\/fonc.2022.953321","volume":"12","author":"XW Guo","year":"2022","unstructured":"Guo XW, Li SQ, Lei RE, Ding Z, Hu BL, Lin R. Tumor-infiltrating immune cells based TMEscore and related gene signature is associated with the survival of CRC patients and response to fluoropyrimidine-based chemotherapy. Front Oncol. 2022;12:953321.","journal-title":"Front Oncol"},{"key":"403_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"403_CR26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/0895-4356(96)00025-X","volume":"49","author":"GW Sun","year":"1996","unstructured":"Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 1996;49:907\u201316.","journal-title":"J Clin Epidemiol"},{"key":"403_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1\u201322.","journal-title":"J Stat Softw"},{"key":"403_CR28","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133.","journal-title":"Bioinformatics"},{"key":"403_CR29","unstructured":"R Core Team. R: A language and environment for statistical computing. In: R Foundation for Statistical Computing. Vienna, Austria (2019). Available at: https:\/\/www.R-project.org\/"},{"key":"403_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","volume":"31","author":"L Yang","year":"2010","unstructured":"Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 2010;31:220\u20137.","journal-title":"Trends Immunol"},{"key":"403_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2015.10.009","volume":"39","author":"DH Munn","year":"2016","unstructured":"Munn DH, Bronte V. Immune suppressive mechanisms in the tumor microenvironment. Curr Opin Immunol. 2016;39:1\u20136.","journal-title":"Curr Opin Immunol"},{"key":"403_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1189\/jlb.5MR1216-508R","volume":"102","author":"ME Shaul","year":"2017","unstructured":"Shaul ME, Fridlender ZG. Neutrophils as active regulators of the immune system in the tumor microenvironment. J Leukoc Biol. 2017;102:343\u20139.","journal-title":"J Leukoc Biol"},{"key":"403_CR33","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1158\/0008-5472.CAN-16-2490","volume":"77","author":"FS Varn","year":"2017","unstructured":"Varn FS, Wang Y, Mullins DW, Fiering S, Cheng C. Systematic pan-cancer analysis reveals immune cell interactions in the tumor microenvironment. Cancer Res. 2017;77:1271\u201382.","journal-title":"Cancer Res"},{"key":"403_CR34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nrc2444","volume":"8","author":"C Murdoch","year":"2008","unstructured":"Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer. 2008;8:618\u201331.","journal-title":"Nat Rev Cancer"},{"key":"403_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12307-010-0038-3","volume":"3","author":"VG Peddareddigari","year":"2010","unstructured":"Peddareddigari VG, Wang D, Dubois RN. The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron. 2010;3:149\u201366.","journal-title":"Cancer Microenviron"},{"key":"403_CR36","first-page":"77","volume":"1","author":"TG Shrihari","year":"2021","unstructured":"Shrihari TG. Innate and adaptive immune cells in tumor microenvironment. Gulf J Oncolog. 2021;1:77\u201381.","journal-title":"Gulf J Oncolog"},{"key":"403_CR37","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545:495\u20139.","journal-title":"Nature"},{"key":"403_CR38","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMoa051424","volume":"353","author":"F Pag\u00e8s","year":"2005","unstructured":"Pag\u00e8s F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353:2654\u201366.","journal-title":"N Engl J Med"},{"key":"403_CR39","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00262-003-0388-5","volume":"52","author":"AC Diederichsen","year":"2003","unstructured":"Diederichsen AC, Hjelmborg J, Christensen PB, Zeuthen J, Fenger C. Prognostic value of the CD4+\/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother. 2003;52:423\u20138.","journal-title":"Cancer Immunol Immunother"},{"key":"403_CR40","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2017.05.022","volume":"67","author":"PF Ma","year":"2017","unstructured":"Ma PF, Gao CC, Yi J, Zhao JL, Liang SQ, Zhao Y, et al. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice. J Hepatol. 2017;67:770\u20139.","journal-title":"J Hepatol"},{"key":"403_CR41","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani P, Boraschi D. From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol. 2014;5:514.","journal-title":"Front Immunol"},{"key":"403_CR42","doi-asserted-by":"publisher","first-page":"e47045","DOI":"10.1371\/journal.pone.0047045","volume":"7","author":"S Edin","year":"2012","unstructured":"Edin S, Wikberg ML, Dahlin AM, Ruteg\u00e5rd J, \u00d6berg \u00c5, Oldenborg PA, et al. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS ONE. 2012;7:e47045.","journal-title":"PLoS ONE"},{"key":"403_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-273","volume":"9","author":"A Rigo","year":"2010","unstructured":"Rigo A, Gottardi M, Zam\u00f2 A, Mauri P, Bonifacio M, Krampera M, et al. Macrophages may promote cancer growth via a GM-CSF\/HB-EGF paracrine loop that is enhanced by CXCL12. Mol Cancer. 2010;9:273.","journal-title":"Mol Cancer"},{"key":"403_CR44","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","volume":"106","author":"P Farinha","year":"2005","unstructured":"Farinha P, Masoudi H, Skinnider BF, Shumansky K, Spinelli JJ, Gill K, et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood. 2005;106:2169\u201374.","journal-title":"Blood"},{"key":"403_CR45","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351:2159\u201369.","journal-title":"N Engl J Med"},{"key":"403_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13045-020-00897-z","volume":"13","author":"D Wang","year":"2020","unstructured":"Wang D, Yu W, Lian J, Wu Q, Liu S, Yang L, et al. Th17 cells inhibit CD8(+) T cell migration by systematically downregulating CXCR3 expression via IL-17A\/STAT3 in advanced-stage colorectal cancer patients. J Hematol Oncol. 2020;13:68.","journal-title":"J Hematol Oncol"},{"key":"403_CR47","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1158\/2326-6066.CIR-21-0137","volume":"9","author":"M Foroutan","year":"2021","unstructured":"Foroutan M, Molania R, Pfefferle A, Behrenbruch C, Scheer S, Kallies A, et al. The ratio of exhausted to resident infiltrating lymphocytes is prognostic for colorectal cancer patient outcome. Cancer Immunol Res. 2021;9:1125\u201340.","journal-title":"Cancer Immunol Res"},{"key":"403_CR48","doi-asserted-by":"publisher","first-page":"108412","DOI":"10.1016\/j.clim.2020.108412","volume":"215","author":"X Zhang","year":"2020","unstructured":"Zhang X, Quan F, Xu J, Xiao Y, Li X, Li Y. Combination of multiple tumor-infiltrating immune cells predicts clinical outcome in colon cancer. Clin Immunol. 2020;215:108412.","journal-title":"Clin Immunol"},{"key":"403_CR49","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1158\/0008-5472.CAN-13-2534","volume":"74","author":"S Ma","year":"2014","unstructured":"Ma S, Cheng Q, Cai Y, Gong H, Wu Y, Yu X, et al. IL-17A produced by \u03b3\u03b4 T cells promotes tumor growth in hepatocellular carcinoma. Cancer Res. 2014;74:1969\u201382.","journal-title":"Cancer Res"},{"key":"403_CR50","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.3390\/pharmaceutics14112468","volume":"14","author":"L Scarabel","year":"2022","unstructured":"Scarabel L, Bignucolo A, Toffoli G, Cecchin E, De Mattia E. Pharmacogenetics role of genetic variants in immune-related factors: a systematic review focusing on mCRC. Pharmaceutics. 2022;14:2468.","journal-title":"Pharmaceutics"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00403-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00403-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00403-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:03:35Z","timestamp":1776834215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00403-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["403"],"URL":"https:\/\/doi.org\/10.1038\/s41397-026-00403-7","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval was not required for this study because all data were obtained from publicly available, de-identified databases (TCGA and GEO), and no identifiable human participant information was involved. All these studies have been previously approved by their respective institutional review boards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"9"}}